Stockholm - Free Realtime Quote SEK
Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
286.80
+7.60
+(2.72%)
As of 10:11:30 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 10 | 10 |
| Avg. Estimate | 1.75 | 4.82 | 14.46 | 19.3 |
| Low Estimate | 1.4 | 4.17 | 11.51 | 13.6 |
| High Estimate | 2.42 | 5.46 | 20.58 | 23.93 |
| Year Ago EPS | 0.72 | 4.31 | 11.69 | 14.46 |
Revenue Estimate
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 11 | 11 |
| Avg. Estimate | 6.21B | 8.11B | 28B | 31.54B |
| Low Estimate | 5.93B | 7.62B | 26.64B | 29.69B |
| High Estimate | 6.73B | 9.06B | 30.18B | 33.79B |
| Year Ago Sales | 5.44B | 6.89B | 26.03B | 28B |
| Sales Growth (year/est) | 14.20% | 17.62% | 7.59% | 12.61% |
Earnings History
| Currency in SEK | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.6 | 2.17 | 2.97 | 1.94 |
| EPS Actual | 0.72 | 4.31 | 3.98 | 2.72 |
| Difference | 0.12 | 2.14 | 1.01 | 0.78 |
| Surprise % | 20.81% | 98.86% | 34.12% | 40.45% |
EPS Trend
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.75 | 4.82 | 14.46 | 19.3 |
| 7 Days Ago | 2.1 | 4.49 | 14.67 | 19.55 |
| 30 Days Ago | 2.1 | 4.49 | 15.45 | 19.64 |
| 60 Days Ago | 1.95 | 5.02 | 15.45 | 19.64 |
| 90 Days Ago | 2.49 | 4.5 | 15.69 | 21.58 |
EPS Revisions
| Currency in SEK | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | 2 | 1 | 1 | 1 |
| Down Last 30 Days | 2 | 1 | 6 | 5 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SOBI.ST | 143.06% | 11.91% | 23.72% | 33.45% |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Downgrade | Barclays: Overweight to Equal-Weight | 2/24/2021 |
Related Tickers
41L.F Laboratorios Farmaceuticos Rovi, S.A.
51.00
-0.20%
603456.SS Zhejiang Jiuzhou Pharmaceutical Co., Ltd
13.92
+0.43%
ROVI.VI Laboratorios Farmaceuticos Rovi, S.A.
50.95
-0.49%
KNSA Kiniksa Pharmaceuticals International, plc
21.47
+0.49%
SDZ.SW Sandoz Group AG
36.62
+1.52%
GALD.SW Galderma Group N
93.00
-0.32%
COLL Collegium Pharmaceutical, Inc.
26.87
+0.30%
MRK.DE Merck KGaA
123.15
+0.37%
ALKS Alkermes plc
27.91
+0.25%
UTHR United Therapeutics Corporation
297.04
+1.94%